Sort
326,823 grants matching “clinical trial”
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis
$1,704,372Stella Sarraf · Amydis Diagnostics, Inc. · SB1 · FY2023 · AG
SPeCTRE: The Sunflower Pediatric Clinical Trials Research Extension
$1,704,265Barbara Angelica Pahud · University Of Kansas Medical Center · UG1 · FY2016 · OD
Cortical reorganization and plasticity In the Healthy Brain
$1,704,263Leonardo G. Cohen · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS
Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose
$1,704,238Marco Pravetoni · University Of Minnesota · UG3 · FY2020 · DA
University of Rochester Center for AIDS Research
$1,704,130Stephen Dewhurst · University Of Rochester · P30 · FY2014 · AI
Mobilizing Community Systems to Engage Families in Early ASD Detection & Services
$1,704,019Amy M Wetherby · Florida State University · R01 · FY2017 · MH
Early Cortical Network Markers of Alzheimer's Disease Risk: a Transcranial Magnetic Stimulation Intervention Trial in Aged Rats
$1,703,998Peter R Rapp · National Institute On Aging · ZIA · FY2019 · AG
Human Energy and Body Weight Regulation Core
$1,703,951Kong Chen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2023 · DK
Identification and Development of Tau-Lowering Small-Molecule Drugs
$1,703,867Lennart Mucke · J. David Gladstone Institutes · R56 · FY2019 · AG
CELLULAR BIOLOGY OF RENAL FUNCTION AND DISEASE
$1,703,577Dennis Brown · Massachusetts General Hospital · P01 · FY2008 · DK
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
$1,703,461James L Abbruzzese · Duke University · UM1 · FY2018 · CA
Clinical Pharmacology Quality Assurance
$1,703,404Eugene Morse · State University Of New York At Buffalo · N01 · FY2021 · AI
Pharmacokinetics and Drug Metabolism
$1,703,261Xin Xu · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
EPITHELIAL OVARIAN CANCER PROGRAM PROJECT
$1,703,177Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,703,139Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2020 · DK
Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with PointCheck: a portable non-invasive neutropenia analyzer
$1,702,979Carlos Castro-Gonzalez · Leuko Labs, Inc. · R44 · FY2024 · CA
University of Kansas Alzheimer's Disease Core Centers
$1,702,927Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2017 · AG
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
$1,702,907James L Abbruzzese · Duke University · UM1 · FY2019 · CA
CORE SUPPORT FOR NICHD CCTN
$1,702,875Jim Higgins · Health Decisions, Inc. · N01 · FY2009 · HD
Papillomavirus Virion Proteins and Vaccines
$1,702,735John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immune Responses to AAV-Mediated FIX Gene Transfer
$1,702,657Hildegund C. J. Ertl · Wistar Institute · P01 · FY2012 · HL
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,702,601Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT
$1,702,555Fred R Sattler · University Of Southern California · U01 · FY2011 · AI
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,702,553Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Strategies to Overcome Immune Resistance in Head and Neck Cancers
$1,702,538Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2022 · CA